应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00853 微创医疗
休市中 03-14 16:08:30
8.730
+0.980
+12.65%
最高
9.090
最低
7.810
成交量
6,569万
今开
7.840
昨收
7.750
日振幅
16.52%
总市值
161.33亿
流通市值
161.33亿
总股本
18.48亿
成交额
5.71亿
换手率
3.55%
流通股本
18.48亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
野村:上调微创医疗目标价至7.73港元 评级“中性”
新浪港股 · 03-11
野村:上调微创医疗目标价至7.73港元 评级“中性”
【券商聚焦】野村维持微创医疗(00853)“中性”评级 料其近两年将继续节流
金吾财讯 · 03-11
【券商聚焦】野村维持微创医疗(00853)“中性”评级 料其近两年将继续节流
微创医疗03月10日主力净流出886万元 散户资金买入
市场透视 · 03-10
微创医疗03月10日主力净流出886万元 散户资金买入
港股午评|恒生指数早盘跌2.11% 港股通标的调整个股波动大
智通财经 · 03-10
港股午评|恒生指数早盘跌2.11% 港股通标的调整个股波动大
摩根大通:维持微创医疗增持评级 上调目标价至10港元
美港电讯 · 03-10
摩根大通:维持微创医疗增持评级 上调目标价至10港元
小摩:维持微创医疗“增持”评级 上调目标价至10港元
新浪港股 · 03-10
小摩:维持微创医疗“增持”评级 上调目标价至10港元
小摩:维持微创医疗(00853)“增持”评级 上调目标价至10港元
智通财经 · 03-10
小摩:维持微创医疗(00853)“增持”评级 上调目标价至10港元
港股异动 | 微创医疗(00853)早盘跌超5% 全年亏损预计收窄58% 小摩看好其26年实现扭亏为盈
智通财经网 · 03-10
港股异动 | 微创医疗(00853)早盘跌超5% 全年亏损预计收窄58% 小摩看好其26年实现扭亏为盈
微创医疗预计2024年收入同比增长近10%
财中社 · 03-09
微创医疗预计2024年收入同比增长近10%
微创医疗(00853)预计2024年度净亏损收窄超58%
智通财经网 · 03-07
微创医疗(00853)预计2024年度净亏损收窄超58%
微创医疗03月07日主力净流入2481万元 散户资金抛售
市场透视 · 03-07
微创医疗03月07日主力净流入2481万元 散户资金抛售
微创医疗盘中异动 早盘股价大涨5.17%
市场透视 · 03-07
微创医疗盘中异动 早盘股价大涨5.17%
微创医疗03月04日获主力加仓436万元
市场透视 · 03-04
微创医疗03月04日获主力加仓436万元
微创医疗盘中异动 大幅下跌5.01%
市场透视 · 02-28
微创医疗盘中异动 大幅下跌5.01%
微创医疗:心脉医疗科技2024年度归母净利润4.98亿元 同比增加1.1%
新浪港股 · 02-28
微创医疗:心脉医疗科技2024年度归母净利润4.98亿元 同比增加1.1%
微创医疗(00853):心脉医疗科技2024年度归母净利润4.98亿元 同比增加1.1%
智通财经 · 02-27
微创医疗(00853):心脉医疗科技2024年度归母净利润4.98亿元 同比增加1.1%
微创医疗盘中异动 急速拉升5.10%报8.250港元
市场透视 · 02-25
微创医疗盘中异动 急速拉升5.10%报8.250港元
微创医疗盘中异动 股价大跌5.15%报7.730港元
市场透视 · 02-24
微创医疗盘中异动 股价大跌5.15%报7.730港元
微创医疗2月18日遭南向资金减持382.68万股
市场透视 · 02-19
微创医疗2月18日遭南向资金减持382.68万股
中国内地投资者周二港股通净买入额创四年来最高
金融界 · 02-19
中国内地投资者周二港股通净买入额创四年来最高
公司概况
公司名称:
微创医疗
所属市场:
SEHK
上市日期:
--
主营业务:
微创医疗科学有限公司是一家主要从事医疗产品制造及销售业务的香港投资控股公司。该公司主要通过七大分部运营。骨科医疗器械分部研究、开发、制造及销售骨科医疗器械。心血管介入产品分部研究、开发、生产及销售心血管用器械,如:药物洗脱支架。大动脉与外周介入产品分部研究、开发、生产及销售大动脉及外周血管介入产品。电生理医疗器械分部研究、开发、制造及销售电生理医疗器械。神经介入产品分部研究、开发、生产及销售神经介入产品。外科医疗器械分部研究、开发、制造及销售外科手术器械。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。
发行价格:
--
{"stockData":{"symbol":"00853","market":"HK","secType":"STK","nameCN":"微创医疗","latestPrice":8.73,"timestamp":1741939710028,"preClose":7.75,"halted":0,"volume":65691637,"delay":0,"floatShares":1848000000,"shares":1848000000,"eps":-2.036029451783201,"marketStatus":"休市中","change":0.98,"latestTime":"03-14 16:08:30","open":7.84,"high":9.09,"low":7.81,"amount":570604571,"amplitude":0.165161,"askPrice":8.74,"askSize":57100,"bidPrice":8.73,"bidSize":5900,"shortable":3,"etf":0,"ttmEps":-1.8143402505112076,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1742175000000},"marketStatusCode":7,"adr":0,"listingDate":1285257600000,"exchange":"SEHK","adjPreClose":7.75,"dividendRate":0.004977,"openAndCloseTimeList":[[1741915800000,1741924800000],[1741928400000,1741939200000]],"volumeRatio":3.338260986498373,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00853/wiki","defaultTab":"wiki","newsList":[{"id":"2518075331","title":"野村:上调微创医疗目标价至7.73港元 评级“中性”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518075331","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518075331?lang=zh_cn&edition=full","pubTime":"2025-03-11 11:09","pubTimestamp":1741662540,"startTime":"0","endTime":"0","summary":" 野村发布研报称,上调微创医疗目标价15%,从6.71港元升至7.73港元,评级“中性”。该行认为微创医疗可能会在2025和2026财年继续节省成本,尤其是在销售额仍然不佳的情况下。 该行称,该公司2024财年初步业绩表明,收入不及指引,但净亏损未差过预期。净亏损同比收窄58%以上至小于2.75亿美元,主要原因是;1)由于成本控制;2)撤资非核心业务获得收益。根据野村的计算,2024年下半年净亏损为1.68亿美元,同比收窄约61%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-11/doc-inepfzsm9815396.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00853"],"gpt_icon":0},{"id":"2518673092","title":"【券商聚焦】野村维持微创医疗(00853)“中性”评级 料其近两年将继续节流","url":"https://stock-news.laohu8.com/highlight/detail?id=2518673092","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518673092?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:44","pubTimestamp":1741661074,"startTime":"0","endTime":"0","summary":"金吾财讯 | 野村发研报指,从微创医疗 2024财年初步业绩来看,收入实现了同比10%的增长,但这一数字低于此前指引的17%。该行进一步计算得出,2024年下半年微创医疗净亏损为1.68亿美元,同比收窄约61%。展望未来,野村预计微创医疗在2025和2026财年可能会继续实施节省成本的措施,特别是考虑到目前销售额仍未达理想水平。维持对微创医疗“中性”评级,并将从6.71港元提升至7.73港元。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954765","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"gpt_icon":0},{"id":"2518219633","title":"微创医疗03月10日主力净流出886万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2518219633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518219633?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:15","pubTimestamp":1741594528,"startTime":"0","endTime":"0","summary":"03月10日, 微创医疗股价跌5.42%,报收7.68元,成交金额2.45亿元,换手率1.71%,振幅7.14%,量比2.05。微创医疗今日主力资金净流出886万元,上一交易日主力净流入2481万元。该股近5个交易日上涨4.47%,主力资金累计净流入2080万元;近20日主力资金累计净流入3135万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310165705a269b87b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310165705a269b87b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1100","BK1583","00853","BK1585"],"gpt_icon":0},{"id":"2518447263","title":"港股午评|恒生指数早盘跌2.11% 港股通标的调整个股波动大","url":"https://stock-news.laohu8.com/highlight/detail?id=2518447263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518447263?lang=zh_cn&edition=full","pubTime":"2025-03-10 12:00","pubTimestamp":1741579233,"startTime":"0","endTime":"0","summary":"深交所10日公告,因恒生综合大型股指数、中型股指数、小型股指数实施成份股定期调整,根据《深圳证券交易所深港通业务实施办法》的有关规定,港股通标的证券名单发生调整并自3月10日起生效。卫龙美味大涨超15%,今日起正式获纳入港股通,公司估值与流动性或迎共振。毛戈平最高涨6%,今日正式获纳入港股通,公司处品牌势能向上快速增长阶段。海伦司重挫逾21%,年内累计跌幅已近35%,今日起遭剔除港股通名单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1190","513600","MCHmain","HSI","LU1481107354.HKD","YANG","BK1589","00853","BK1100","BK1592","HSTECH","LU0164880469.USD","03993","HSCEI","BK1583","BK1585","02833","BK1594","BK4614","LU0149721374.USD","HHImain"],"gpt_icon":1},{"id":"2518263834","title":"摩根大通:维持微创医疗增持评级 上调目标价至10港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518263834","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518263834?lang=zh_cn&edition=full","pubTime":"2025-03-10 11:58","pubTimestamp":1741579119,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1261432733.SGD","BK4011","IE00BHPRN162.USD","LU2264538146.SGD","LU0971096721.USD","LU1894683348.USD","IE00BLSP4452.SGD","IE00BYXW3230.USD","LU0787776722.HKD","LU1267930490.SGD","IE0034235295.USD","LU1119994496.HKD","LU1363072403.SGD","LU0256863811.USD","IE00BZ1G4Q59.USD","LU0820561818.USD","BK4581","LU0868494708.USD","IE00BKVL7J92.USD","SMID","LU0211328371.USD","LU1084165304.USD","LU0234572021.USD","BK4534","LU0417517546.SGD","IE00BKDWB100.SGD","LU1244550221.USD","SG9999002232.USD","BK1589","IE00BDCRKT87.USD","LU0689472784.USD","LU0070302665.USD","LU1670628061.USD","LU0320765646.SGD","LU2430703095.HKD","159891","LU2756315664.SGD","IE00BDRTCR15.USD","LU2505996681.GBP","LU1974910355.USD","BK4207","02252","BK1583","BK4585","BK4588","00853","LU0106831901.USD","IE00BJLML261.HKD","LU0882574139.USD","LU1894683264.USD"],"gpt_icon":0},{"id":"2518579263","title":"小摩:维持微创医疗“增持”评级 上调目标价至10港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518579263","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518579263?lang=zh_cn&edition=full","pubTime":"2025-03-10 11:56","pubTimestamp":1741578960,"startTime":"0","endTime":"0","summary":" 摩根大通发布研报称,维持微创医疗“增持”评级,目标价由8港元上调至10港元。该行重申,对微创医疗持积极看法,形容在中小型医疗技术领域中,集团是多元化本地领导者,具有强大的创新能力、海外市场扩张能力,并且预计至2026年可扭亏为盈;又指集团仍然是该行在SMID医疗技术领域的首选。 小摩指出,微创机器人-B订单趋势强劲,它是微创医疗旗下重要子公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-10/doc-inepcwtn0748097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00853"],"gpt_icon":0},{"id":"2518126807","title":"小摩:维持微创医疗(00853)“增持”评级 上调目标价至10港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518126807","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518126807?lang=zh_cn&edition=full","pubTime":"2025-03-10 11:45","pubTimestamp":1741578322,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,摩根大通发布研报称,维持微创医疗(00853)“增持”评级,目标价由8港元上调至10港元。该行重申,对微创医疗持积极看法,形容在中小型医疗技术领域(SMID)中,集团是多元化本地领导者,具有强大的创新能力、海外市场扩张能力,并且预计至2026年可扭亏为盈;又指集团仍然是该行在SMID医疗技术领域的首选。小摩指出,微创机器人-B(02252)订单趋势强劲,它是微创医疗旗下重要子公司。预计由于中国和海外机器人安装的快速扩张,前者对集团销售贡献将由2024年的约3%升至2033年的约40%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00853","02252"],"gpt_icon":0},{"id":"2518250440","title":"港股异动 | 微创医疗(00853)早盘跌超5% 全年亏损预计收窄58% 小摩看好其26年实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2518250440","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518250440?lang=zh_cn&edition=full","pubTime":"2025-03-10 11:13","pubTimestamp":1741576380,"startTime":"0","endTime":"0","summary":"微创医疗早盘跌超5%,截至发稿,跌5.54%,报7.67港元,成交额1.57亿港元。消息面上,微创医疗发布盈警,预计2024年度净亏损不超过2.75亿美元,同比收窄超过58%。小摩发表研报称,对微创医疗持积极看法,形容在中小型医疗技术领域中,集团是多元化本地领导者,具有强大的创新能力、海外市场扩张,并且预计至2026年可扭亏为盈;又指集团仍然是该行在SMID医疗技术领域的首选。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-10/doc-inepcsmq0865504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0820561818.USD","LU0320765646.SGD","LU0868494617.USD","LU1551013342.USD","IE00BKDWB100.SGD","LU2552382132.HKD","LU2023250504.SGD","BK4516","IE000M9KFDE8.USD","IE00BJTD4N35.SGD","LU0882574139.USD","LU1670628061.USD","LU0417517546.SGD","LU0683600562.USD","LU0976567544.SGD","LU0238689110.USD","LU0267386448.USD","LU0211331839.USD","LU0868494708.USD","00853","LU0106831901.USD","LU0203347892.USD","LU0251132253.USD","LU2106854487.HKD","LU1496350502.SGD","LU2264538146.SGD","BK4581","LU2242649171.HKD","LU0496365809.HKD","LU0234572021.USD","IE00BWXC8680.SGD","LU0211327993.USD","LU1917777945.USD","BK4550","BK4534","LU1244550221.USD","LU1894683348.USD","IE00BHPRN162.USD","LU2505996681.GBP","IE00B1XK9C88.USD","LU2505996509.AUD","LU2430703095.HKD","LU1145028129.USD","LU1914381329.SGD","LU2237443978.SGD","LU2430703178.SGD","LU1629891620.HKD","LU1668664300.SGD","BK4588","BK1585"],"gpt_icon":0},{"id":"2518061664","title":"微创医疗预计2024年收入同比增长近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518061664","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518061664?lang=zh_cn&edition=full","pubTime":"2025-03-09 16:38","pubTimestamp":1741509513,"startTime":"0","endTime":"0","summary":"3月9日,微创医疗(00853)发布公告,预计截至2024年12月31日的年度业绩将实现近10%的收入增长,尽管面临快速变化的外部环境和行业政策影响。根据初步评估,预计净亏损不超过2.75亿美元,较上年同期的亏损收窄超过58%。这一预期亏损的显著收窄主要归因于公司在报告期内实施的资源聚焦和成本优化措施,使得经营费用占收入比率同比下降约28个百分点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503093340500554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","BK1585","BK1583","BK1589","00853"],"gpt_icon":0},{"id":"2517436589","title":"微创医疗(00853)预计2024年度净亏损收窄超58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517436589","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517436589?lang=zh_cn&edition=full","pubTime":"2025-03-07 22:12","pubTimestamp":1741356773,"startTime":"0","endTime":"0","summary":"微创医疗(00853)发布公告,于截至2024年12月31日止12个月,尽管面对快...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1589","00853","BK1585","BK1100","BK1583"],"gpt_icon":0},{"id":"2517103073","title":"微创医疗03月07日主力净流入2481万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517103073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517103073?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:15","pubTimestamp":1741335331,"startTime":"0","endTime":"0","summary":"03月07日, 微创医疗股价涨5.05%,报收8.12元,成交金额2.49亿元,换手率1.66%,振幅9.83%,量比1.91。微创医疗今日主力资金净流入2481万元,上一交易日主力净流出196万元。该股近5个交易日上涨8.99%,主力资金累计净流入3292万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入8023万元,其中净流入天数为10日。该股主力净额占比0.17%,港股市场排名53/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165957abecc4c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307165957abecc4c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1100","BK1583","BK1589","00853"],"gpt_icon":0},{"id":"2517429091","title":"微创医疗盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517429091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517429091?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:36","pubTimestamp":1741315017,"startTime":"0","endTime":"0","summary":"2025年03月07日早盘10时36分,微创医疗股票出现波动,股价快速上涨5.17%。截至发稿,该股报8.130港元/股,成交量852.86万股,换手率0.46%,振幅6.73%。微创医疗股票所在的医疗设备及用品行业中,整体涨幅为0.06%。其相关个股中,百心安-B、心通医疗-B、加和国际控股涨幅较大,振幅较大的相关个股有百心安-B、微创机器人-B、心通医疗-B,振幅分别为18.26%、8.69%、8.00%。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307103657963ce5fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307103657963ce5fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1583","BK1589","00853","BK1100"],"gpt_icon":0},{"id":"2516625931","title":"微创医疗03月04日获主力加仓436万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516625931?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:37","pubTimestamp":1741081074,"startTime":"0","endTime":"0","summary":"03月04日, 微创医疗股价涨0.81%,报收7.44元,成交金额7184万元,换手率0.53%,振幅4.88%,量比0.33。微创医疗今日主力资金净流入436万元,上一交易日主力净流入326万元。该股近5个交易日下跌10.43%,主力资金累计净流出2523万元;近20日主力资金累计净流入7831万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304173947a25ea3a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304173947a25ea3a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","00853","BK1100","BK1585","BK1589"],"gpt_icon":0},{"id":"2514369712","title":"微创医疗盘中异动 大幅下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514369712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514369712?lang=zh_cn&edition=full","pubTime":"2025-02-28 09:49","pubTimestamp":1740707388,"startTime":"0","endTime":"0","summary":"2025年02月28日早盘09时49分,微创医疗股票出现波动,股价大幅下挫5.01%。截至发稿,该股报7.780港元/股,成交量505.86万股,换手率0.27%,振幅5.01%。微创医疗股票所在的医疗设备及用品行业中,整体跌幅为0.17%。其相关个股中,紫元元、微泰医疗-B、鹰瞳科技-B涨幅较大,振幅较大的相关个股有微创机器人-B、先健科技、中国卫生集团,振幅分别为8.49%、5.06%、5.05%。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022809494898959fcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022809494898959fcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1585","BK1589","00853","BK1583"],"gpt_icon":0},{"id":"2514914368","title":"微创医疗:心脉医疗科技2024年度归母净利润4.98亿元 同比增加1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514914368","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514914368?lang=zh_cn&edition=full","pubTime":"2025-02-28 08:33","pubTimestamp":1740702780,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 微创医疗(00853)发布心脉医疗科技截至2024年12月31日止12个月业绩,收入12.06亿元(人民币,下同),同比增加1.6%;归属于心脉医疗科技股权持有人的净利润4.98亿元,同比增加1.1%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-28/doc-inemyxct2534269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688016","00853"],"gpt_icon":0},{"id":"2514780715","title":"微创医疗(00853):心脉医疗科技2024年度归母净利润4.98亿元 同比增加1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514780715","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514780715?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:44","pubTimestamp":1740663857,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创医疗(00853)发布心脉医疗科技截至2024年12月31日止12个月业绩,收入12.06亿元(人民币,下同),同比增加1.6%;归属于心脉医疗科技股权持有人的净利润4.98亿元,同比增加1.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255701.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00853","688016"],"gpt_icon":0},{"id":"2514087225","title":"微创医疗盘中异动 急速拉升5.10%报8.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514087225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514087225?lang=zh_cn&edition=full","pubTime":"2025-02-25 10:29","pubTimestamp":1740450546,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘10时29分,微创医疗股票出现异动,股价急速上涨5.10%。截至发稿,该股报8.250港元/股,成交量1239.68万股,换手率0.67%,振幅9.55%。资金方面,该股资金流入5832.48万港元,流出2523.51万港元。微创医疗股票所在的医疗设备及用品行业中,整体涨幅为0.25%。其相关个股中,微创机器人-B、微创医疗、微创脑科学涨幅较大,振幅较大的相关个股有微创机器人-B、微创医疗、微创脑科学,振幅分别为23.44%、9.43%、9.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225102906abdbad87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225102906abdbad87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","00853","BK1100","BK1583","BK1589"],"gpt_icon":0},{"id":"2513670097","title":"微创医疗盘中异动 股价大跌5.15%报7.730港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513670097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513670097?lang=zh_cn&edition=full","pubTime":"2025-02-24 09:34","pubTimestamp":1740360894,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘09时34分,微创医疗股票出现波动,股价急速跳水5.15%。截至发稿,该股报7.730港元/股,成交量254.49万股,换手率0.14%,振幅5.89%。资金方面,该股资金流入752.165万港元,流出906.387万港元。微创医疗股票所在的医疗设备及用品行业中,整体涨幅为0.09%。其相关个股中,康基医疗、先瑞达医疗-B、健世科技-B涨幅较大,振幅较大的相关个股有复锐医疗科技、微创医疗、微创机器人-B,振幅分别为6.32%、5.89%、5.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409345598902b95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022409345598902b95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","00853","BK1585","BK1583","BK1100"],"gpt_icon":0},{"id":"2512481691","title":"微创医疗2月18日遭南向资金减持382.68万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2512481691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512481691?lang=zh_cn&edition=full","pubTime":"2025-02-19 09:30","pubTimestamp":1739928613,"startTime":"0","endTime":"0","summary":"2月18日,南向资金减持微创医疗382.68万股。截止当日收盘,港股通共持有微创医疗62084.99万股,占流通股33.60%。微创医疗近5个交易日上涨9.82%,港股通累计减持1789.58万股;近20个交易日上涨45.42%,港股通累计减持2606.47万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219093045a24b35d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219093045a24b35d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1585","BK1583","BK1589","00853"],"gpt_icon":0},{"id":"2512111961","title":"中国内地投资者周二港股通净买入额创四年来最高","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111961","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512111961?lang=zh_cn&edition=full","pubTime":"2025-02-19 07:37","pubTimestamp":1739921873,"startTime":"0","endTime":"0","summary":"中国内地投资者周二通过港股通净买入224亿港元的香港股票,继续推动DeepSeek引发的科技股涨势。彭博数据显示,这是自2021年初以来最大单日净买入,也是有纪录以来第四高。恒生科技指数当日大涨2.5%,有望连续第六周上涨。内地资金大量涌入香港股市,已推动A股市场相较港股的溢价幅度缩小至约34%,这使得一项A-H股溢价指数接近在过去总会触发反弹的底部,引发了香港上市中资股跑赢内地股票的幅度可能缩小的担忧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190739199627f2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02380","00003","09688","09890","01686","03606","00762","01138","HSCEI","01405","00152","02382","02172","03311","01888","03918","00751","00939","01818","00107","01128","06690","03888","00590","00014","00548","01787","02386","00189","00293","01024","06127","09885","02601","00467","02005","01052","00005","01675","06936","00868","03968","02158","00772","02618","BK1133","01066","02367","BK1506","SG9999002463.SGD","06616","00576","02359","00666","00819","03690","00327","00512","02533","01071","03396","00659","01618","02105","03988","00288","00316","01112","00148","00241","09868","00788","00270","00412","00867","00836","01119","01513","01691","02208","00425","02099","00008","06818","00392","03933","03360","02600","03369","01876","02333","01658","02186","01855","03800","00142","02155","02269","06069","BK1536","02883","00300","06821","00006","03328","01789","09988","01919","01810","06618","00144","02162","09626","00855","02268","02096","06160","00257","09992","01519","02015","06198","01772","01070","02607","00728","01541","09987","02057","09899","01093","00177","00861","01735","02688","09923","06110","BK1589","01347","00303","06855","02157","09995","01558","02121","02171","00856","00220","01579","01929","02338","09696","01921","06181","09858","01193","02498","00267","00384","01211","00981","01907","06990","03618","06699","09969","00546","00175","01585","01766","06808","02018","06060","01177","01963","06186","00038","01310","01357","01860","02016","00317","09926","00853","01530","00371","02465","01341","01952","02291","06680","01199","00826","03650","00991","00013","02400","03692","02282","HSTECH","03969","00777","09880","09922","02402"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microport.com.cn","stockEarnings":[{"period":"1week","weight":0.0751},{"period":"1month","weight":0.1829},{"period":"3month","weight":0.3267},{"period":"6month","weight":0.7084},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.3662}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":0.0962},{"period":"3month","weight":0.1997},{"period":"6month","weight":0.3795},{"period":"1year","weight":0.4126},{"period":"ytd","weight":0.1944}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创医疗科学有限公司是一家主要从事医疗产品制造及销售业务的香港投资控股公司。该公司主要通过七大分部运营。骨科医疗器械分部研究、开发、制造及销售骨科医疗器械。心血管介入产品分部研究、开发、生产及销售心血管用器械,如:药物洗脱支架。大动脉与外周介入产品分部研究、开发、生产及销售大动脉及外周血管介入产品。电生理医疗器械分部研究、开发、制造及销售电生理医疗器械。神经介入产品分部研究、开发、生产及销售神经介入产品。外科医疗器械分部研究、开发、制造及销售外科手术器械。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.003773},{"month":2,"riseRate":0.466667,"avgChangeRate":0.014634},{"month":3,"riseRate":0.533333,"avgChangeRate":0.031881},{"month":4,"riseRate":0.428571,"avgChangeRate":0.027977},{"month":5,"riseRate":0.571429,"avgChangeRate":0.030356},{"month":6,"riseRate":0.428571,"avgChangeRate":0.038173},{"month":7,"riseRate":0.5,"avgChangeRate":-0.0126},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.048949},{"month":9,"riseRate":0.571429,"avgChangeRate":0.024872},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018452},{"month":11,"riseRate":0.466667,"avgChangeRate":0.010466},{"month":12,"riseRate":0.4,"avgChangeRate":-0.013828}],"exchange":"SEHK","name":"微创医疗","nameEN":"MICROPORT"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创医疗,00853,微创医疗股票,微创医疗股票老虎,微创医疗股票老虎国际,微创医疗行情,微创医疗股票行情,微创医疗股价,微创医疗股市,微创医疗股票价格,微创医疗股票交易,微创医疗股票购买,微创医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}